Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016;94:739–46. https://doi.org/10.1007/s00109-016-1427-y.

Article  Google Scholar 

Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E Genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349–56. https://doi.org/10.1001/jama.1997.03550160069041.

Article  PubMed  Google Scholar 

Minta K, Brinkmalm G, Janelidze S, Sjödin S, Portelius E, Stomrud E, Zetterberg H, Blennow K, Hansson O, Andreasson U. Quantification of total Apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases. Alzheimer’s Res Ther. 2020;12(1):19. https://doi.org/10.1186/s13195-020-00585-7.

Article  Google Scholar 

Blanchard V, Ramin-Mangata S, Billon-Crossouard S, Aguesse A, Durand M, Chemello K, Nativel B, Flet L, Chétiveaux M, Jacobi D, Bard J-M, Ouguerram K, Lambert G, Krempf M, Croyal M. Kinetics of Plasma Apolipoprotein E Isoforms by LC-MS/MS: a pilot study. J Lipid Res. 2018;59(5):892–900. https://doi.org/10.1194/jlr.P083576.

Article  PubMed  PubMed Central  Google Scholar 

Rasmussen KL. Plasma levels of Apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review. Atherosclerosis. 2016;255:145–55. https://doi.org/10.1016/j.atherosclerosis.2016.10.037.

Article  PubMed  Google Scholar 

Mahley RW, Huang Y, Rall SC. Pathogenesis of Type III Hyperlipoproteinemia (Dysbetalipoproteinemia): Questions, Quandaries, and Paradoxes. J Lipid Res. 1999;40(11):1933–49. https://doi.org/10.1016/S0022-2275(20)32417-2.

Article  PubMed  Google Scholar 

Mahley RW, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–37. https://doi.org/10.1146/annurev.genom.1.1.507.

Article  PubMed  Google Scholar 

Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Association of Apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298(11):1300–11. https://doi.org/10.1001/jama.298.11.1300.

Article  PubMed  Google Scholar 

Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012;76(5):871–85. https://doi.org/10.1016/j.neuron.2012.11.020.

Article  PubMed  PubMed Central  Google Scholar 

Husain MA, Laurent B, Plourde M. APOE and Alzheimer’s Disease: from lipid transport to physiopathology and therapeutics. Front Neurosci. 2021;15:67.

Article  Google Scholar 

Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang L-S, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang J-J, Hsu W-C, Chen Y-L, Toga AW. Apolipoprotein E Genotype and Sex risk factors for Alzheimer Disease: a meta-analysis. JAMA Neurol. 2017;74(10):1178–89. https://doi.org/10.1001/jamaneurol.2017.2188.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: Protective mechanism and therapeutic implications for Alzheimer’s disease. Mol Neurodegener. 2020;15(1):63. https://doi.org/10.1186/s13024-020-00413-4.

Article  PubMed  PubMed Central  Google Scholar 

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang L-S, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11(1):667. https://doi.org/10.1038/s41467-019-14279-8.

Article  PubMed  PubMed Central  Google Scholar 

Mooijaart SP, Berbée JFP, Heemst D, van; Havekes, L. M., Craen, A. J. M. de; Slagboom, P. E., Rensen, P. C. N., Westendorp, R. G. J. ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med. 2006;3(6): e176. https://doi.org/10.1371/journal.pmed.0030176.

Article  PubMed  PubMed Central  Google Scholar 

Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on Apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet. 1988;42(1):104–12.

PubMed  PubMed Central  Google Scholar 

Haddy N, Bacquer DD, Chemaly MM, Maurice M, Ehnholm C, Evans A, Sans S, Martins MC, Backer GD, Siest G, Visvikis S. The Importance of Plasma Apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet. 2002;10(12):841–50. https://doi.org/10.1038/sj.ejhg.5200864.

Article  PubMed  Google Scholar 

Siest G, Bertrand P, Qin B, Herbeth B, Serot J-M, Masana L, Ribalta J, Passmore AP, Evans A, Ferrari M, Franceschi M, Shepherd J, Cuchel M, Beisiegel U, Zuchowsky K, Rukavina AS, Sertic J, Stojanov M, Kostic V, Mitrevski A, Petrova V, Sass C, Merched A, Salonen JT, Tiret L, Visvikis S. Group13, the A Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer’s Disease in Nine European Centres: The ApoEurope Study. Disease. 2000;38(8):721–30. https://doi.org/10.1515/CCLM.2000.102.

Article  Google Scholar 

Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN. Plasma Apolipoprotein E and Alzheimer Disease Risk: The AIBL Study of Aging. Neurology. 2011;76(12):1091–8. https://doi.org/10.1212/WNL.0b013e318211c352.

Article  PubMed  Google Scholar 

Slooter AJC, de Knijff P, Hofman A, Cruts M, Breteler MMB, Van Broeckhoven C, Havekes LM, van Duijn CM. Serum Apolipoprotein E Level Is Not Increased in Alzheimer’s Disease: The Rotterdam Study. Neurosci Lett. 1998;248(1):21–4. https://doi.org/10.1016/S0304-3940(98)00339-5.

Article  PubMed  Google Scholar 

Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, Siuciak JA, Kaplow J, Thambisetty M, Zagouras P, Koroshetz WJ, Wan HI, Trojanowski JQ, Shaw LM. Biomarkers Consortium Alzheimer’s Disease Plasma Proteomics Project, for the Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease. Arch Neurol. 2012;69(10):1310–7. https://doi.org/10.1001/archneurol.2012.1070.

Article  PubMed  PubMed Central  Google Scholar 

Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, Schiavon R, Corbo RM. Plasma Levels of Apolipoprotein E and genetic markers in elderly patients with Alzheimer’s Disease. Neurosci Lett. 1999;259(1):33–6. https://doi.org/10.1016/S0304-3940(98)00889-1.

Article  PubMed  Google Scholar 

McConnell LM, Koenig BA, Greely HT, Raffin TA. Genetic Testing and Alzheimer disease: has the time come? Nat Med. 1998;4(7):757–9. https://doi.org/10.1038/nm0798-757.

Article  PubMed  Google Scholar 

Zick CD, Mathews CJ, Roberts JS, Cook-Deegan R, Pokorski RJ, Green RC. Genetic testing for Alzheimer’s Disease and its impact on insurance purchasing behavior. Health Aff. 2005;24(2):483–90. https://doi.org/10.1377/hlthaff.24.2.483.

Article  Google Scholar 

Simon R, Girod M, Fonbonne C, Salvador A, Clément Y, Lantéri P, Amouyel P, Lambert JC, Lemoine J. Total ApoE and ApoE4 Isoform Assays in an Alzheimer’s Disease case-control study by targeted mass spectrometry (n = 669): a pilot assay for methionine-containing proteotypic peptides *. Mol Cell Proteomics. 2012;11(11):1389–403. https://doi.org/10.1074/mcp.M112.018861.

Article  PubMed  PubMed Central  Google Scholar 

Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Jackson EN, Harpstrite SE, Verghese PB, West T, Fogelman I, Braunstein JB, Yarasheski KE, Contois JH. The PrecivityAD™ Test: accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and Apolipoprotein E proteotype for the assessment of brain amyloidosis. Clin Chim Acta. 2021;519:267–75. https://doi.org/10.1016/j.cca.2021.05.011.

Article  PubMed  Google Scholar 

Begcevic Brkovic I, Zöhrer B, Scholz M, Reinicke M, Dittrich J, Kamalsada S, Baber R, Beutner F, Teren A, Engel C, Wirkner K, Thiele H, Löffler M, Riedel-Heller SG, Ceglarek U. Simultaneous mass spectrometry-based apolipoprotein profiling and apolipoprotein E phenotyping in patients with ASCVD and mild cognitive impairment. Nutrients. 2022;14(12):2474. https://doi.org/10.3390/nu14122474.

Article  PubMed  PubMed Central  Google Scholar 

Hu Y, Meuret C, Go S, Yassine HN, Nedelkov D. Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid. J Alzheimers Dis. 2020;76(3):883–93. https://doi.org/10.3233/JAD-200203.

Article  PubMed  PubMed Central  Google Scholar